Geopolitical tensions are increasing
Recently Russia once again exhibited its missiles and other military vehicles. Saudi Arabia is upgrading and Turkey is also buying rocket systems from Russia and wants aircraft from the USA. And then there is China, whose military strength is becoming more and more remarkable. In the USA, these movements have not gone unnoticed. The military there is therefore hardly neglected. But not only new technologically sophisticated weapon systems belong to the equipment of a militant army.
Nutrition must also be perfected. Innovative companies such as EnWave - http://www.commodity-tv.net/c/search_adv/?v=299137 - can benefit from this. The Canadians have developed a unique system for drying food and pharmaceuticals. This is based on microwave technology and can dry the ingredients more quickly and gently. This has not escaped the attention of the U.S. military. Therefore, it has been working with EnWave for some time to develop field catering for the troops that is better than the previous one.
However, EnWave is not only on the move on military railways. On the contrary, this segment is rather small today. Currently, the application of the technology in the field of medical cannabis could become much more fruitful. This could speed up the development of medical products. Companies with activities in the cannabis sector, such as RavenQuest Biomed, benefit from this in turn.
RavenQuest BioMed - http://www.commodity-tv.net/c/search_adv/?v=299207 - owns cannabis acreage in Canada and the necessary sales license from Health Canada. RavenQuest BioMed is working with the Norwegian company Biocare to develop Europe as well. A large part of the expected high-quality harvest has already been sold. RavenQuest BioMed is not only active in production, but also in research, working with McGill University.
Current company information and press releases from EnWave (https://www.resource-capital.ch/en/companies/enwave-corp/) and RavenQuest BioMed (https://www.resource-capital.ch/en/companies/ravenquest-biomed-inc/).
In accordance with §34 WpHG, I would like to point out that partners, authors and employees can hold shares in the companies mentioned in each case and therefore there is a possible conflict of interest. Only the German version of these messages applies.
Disclaimer: The information provided does not constitute any form of recommendation or advice. We expressly point out the risks involved in securities trading. No liability can be assumed for damages resulting from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. I expressly reserve the right to make a mistake, in particular with regard to figures and exchange rates, despite the utmost care. The information contained herein has been obtained from sources believed to be reliable but does not claim to be accurate or complete. Due to court rulings the contents of linked external sites are also to answer for (so among other things district court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no explicit dissociation from these takes place. Despite careful control of the contents, I do not assume any liability for the contents of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: https://www.resource-capital.ch/en/disclaimer/